Inflammatory diseases of the vessels
- Role of interleukin-6 and Th17 lymphocyte profile in the pathogenesis of large vessel vasculitis
- Evaluation of the diagnostic, prognostic and therapeutic potential of miRNAs in giant cell arteritis
- Insight into the heterogeneity of giant cell arteritis for tailored therapies
- Expression and role of inteleukine-36 in Giant Cell Arteritis
- Molecular stratification of patients with giant cell arteritis to tailor glucocorticoid and tocilizumab therapy
- Prospective observational study in patients with GCA treated with steroid boluses and Tocilizumab: role of imaging
- Effects of Tuftsin-phosphorylcholine (TPC) in large vessel vasculitis and uveitis associated with HLA-B27
- Immune checkpoints as biomarkers of disease activity in large vessel vasculitis
- Phenotype and cytokines of monocytes as biomarkers for monitoring disease activity in large vessel vasculitis
- microRNAs deregulation in ANCA-associated vasculitis
- Phenotypic and functional evaluation of circulating Natural Killer (NK) cells and aqueous humor in Behçet disease patients with ocular involvement and in the active phase
- NKG2D, a potential therapeutic target in Behcet's disease
- NKG2D transcripts for monitoring disease activity and diagnosis in subjects with Behcet's syndrome
- Interaction between the immune system and tissue cells in Behcet's disease
- Evaluation of the regenerative potential of platelet concentrates for the treatment of difficult-to-heal skin ulcers in collaboration with the Laboratory of Biochemistry and Metabolomics
Ultimo aggiornamento: 12/01/24